Frequent Infection of Cats With SARS-CoV-2 Irrespective of Pre-Existing Enzootic Coronavirus Immunity, Brazil 2020.

Autor: de Oliveira-Filho EF; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., de Carvalho OV; Tecsa Laboratorios, Belo Horizonte, Brazil., Carneiro IO; School of Veterinary Medicine and Zootechny, Federal University of Bahia, Salvador, Brazil., Fernandes FD; Department of Veterinary Medicine, Federal University of Santa Maria, Santa Maria, Brazil., Vaz SN; Disease Research Laboratory, University Hospital Professor Edgard Santos, Federal University of Bahia, Salvador, Brazil., Pedroso C; Disease Research Laboratory, University Hospital Professor Edgard Santos, Federal University of Bahia, Salvador, Brazil., Gonzalez-Auza L; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Urbieta VC; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Kühne A; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Mayoral R; School of Veterinary Medicine and Zootechny, Federal University of Bahia, Salvador, Brazil., Jo WK; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Moreira-Soto A; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Reusken CBEM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands., Drosten C; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany., Brites C; Disease Research Laboratory, University Hospital Professor Edgard Santos, Federal University of Bahia, Salvador, Brazil., Osterrieder K; Institut für Virologie, Freie Universität Berlin, Berlin, Germany., Netto EM; Disease Research Laboratory, University Hospital Professor Edgard Santos, Federal University of Bahia, Salvador, Brazil., Ristow LE; Tecsa Laboratorios, Belo Horizonte, Brazil., Maia RC; Veterinary Medicine Department, Federal Rural University of Pernambuco, Recife, Brazil., Vogel FSF; Department of Veterinary Medicine, Federal University of Santa Maria, Santa Maria, Brazil., de Almeida NR; School of Veterinary Medicine and Zootechny, Federal University of Bahia, Salvador, Brazil., Franke CR; School of Veterinary Medicine and Zootechny, Federal University of Bahia, Salvador, Brazil., Drexler JF; Institute of Virology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.; German Centre for Infection Research (DZIF), Associated Partner Site Charité, Berlin, Germany.
Jazyk: angličtina
Zdroj: Frontiers in immunology [Front Immunol] 2022 Apr 05; Vol. 13, pp. 857322. Date of Electronic Publication: 2022 Apr 05 (Print Publication: 2022).
DOI: 10.3389/fimmu.2022.857322
Abstrakt: Carnivores such as cats and minks are highly susceptible to SARS-CoV-2. Brazil is a global COVID-19 hot spot and several cases of human-to-cat transmission have been documented. We investigated the spread of SARS-CoV-2 by testing 547 domestic cats sampled between July-November 2020 from seven states in southern, southeastern, and northeastern Brazil. Moreover, we investigated whether immune responses elicited by enzootic coronaviruses affect SARS-CoV-2 infection in cats. We found infection with significantly higher neutralizing antibody titers against the Gamma variant of concern, endemic in Brazil during 2020, than against an early SARS-CoV-2 B.1 isolate (p<0.0001), validating the use of Gamma for further testing. The overall SARS-CoV-2 seroprevalence in Brazilian cats during late 2020 validated by plaque reduction neutralization test (PRNT 90 ) was 7.3% (95% CI, 5.3-9.8). There was no significant difference in SARS-CoV-2 seroprevalence in cats between Brazilian states, suggesting homogeneous infection levels ranging from 4.6% (95% CI, 2.2-8.4) to 11.4% (95% CI, 6.7-17.4; p=0.4438). Seroprevalence of the prototypic cat coronavirus Feline coronavirus (FCoV) in a PRNT 90 was high at 33.3% (95% CI, 24.9-42.5) and seroprevalence of Bovine coronavirus (BCoV) was low at 1.7% (95% CI, 0.2-5.9) in a PRNT 90 . Neutralizing antibody titers were significantly lower for FCoV than for SARS-CoV-2 (p=0.0001), consistent with relatively more recent infection of cats with SARS-CoV-2. Neither the magnitude of SARS-CoV-2 antibody titers (p=0.6390), nor SARS-CoV-2 infection status were affected by FCoV serostatus (p=0.8863). Our data suggest that pre-existing immunity against enzootic coronaviruses neither prevents, nor enhances SARS-CoV-2 infection in cats. High SARS-CoV-2 seroprevalence already during the first year of the pandemic substantiates frequent infection of domestic cats and raises concerns on potential SARS-CoV-2 mutations escaping human immunity upon spillback.
Competing Interests: Authors OC and LR were employed by company Tecsa Laboratorios. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
(Copyright © 2022 Oliveira-Filho, de Carvalho, Carneiro, Fernandes, Vaz, Pedroso, Gonzalez-Auza, Urbieta, Kühne, Mayoral, Jo, Moreira-Soto, Reusken, Drosten, Brites, Osterrieder, Netto, Ristow, Maia, Vogel, Almeida, Franke and Drexler.)
Databáze: MEDLINE
Externí odkaz: